The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

You’ve heard of drugs like marijuana, cocaine, and pain medications being used recreationally, but what about…laughing gas? While nitrous oxide has clinical and medicinal purposes – such as sedating ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

FAA imposes helicopter restrictions near Reagan National Airport; U.S. readies for tariffs on imports from Mexico, Canada and ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.